Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation

Details for Australian Patent Application No. 2005216879 (hide)

Owner Sanofi-Aventis Deutschland GmbH Aventis Pharmaceuticals Inc

Inventors Minnich, Anne; Lang, Han-Jochen; Kuntzweiler, Theresa; Eishingdrelo, Haifeng; Angelastro, Michael

Agent Watermark

Pub. Number AU-B-2005216879

PCT Pub. Number WO2005/082350

Priority 60/546,011 20.02.04 US

Filing date 10 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 10 December 2009

International Classifications

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

C07D 207/335 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/082350 Priority application(s): WO2005/082350

10 December 2009 Application Accepted

  Published as AU-B-2005216879

8 April 2010 Standard Patent Sealed

6 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216883-Apparatus and method for separating a volume of composite liquid into at least two components

2005216878-Oxydecahydronaphthalene modulators of HM74